Enveric Biosciences, Inc. (ENVB) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 33 transactions totaling $2.1K, demonstrating a bullish sentiment with $2.1K in net insider flow. The most recent transaction on Dec 23, 2025 involved a transaction of 40,198 shares valued at $0.
No significant insider buying has been recorded for ENVB in the recent period.
No significant insider selling has been recorded for ENVB in the recent period.
Based on recent SEC filings, insider sentiment for ENVB is bullish with an Insider Alignment Score of 100/100 and a net flow of $2.1K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Enveric Biosciences, Inc. (ENVB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading ENVB stock, having executed 33 transactions in the past 90 days. The most active insider is Frank Pasqualone (Executive), who has made 2 transactions totaling $2.1K.
Get notified when executives and directors at ENVB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | Michael Coveney Kevin | Executive | Award | 40,198 | $N/A | $0 | |
| Dec 23, 2025 | D. Webb Michael | Executive | Award | 7,633 | $N/A | $0 | |
| Dec 23, 2025 | Edward Tucker Joseph | Executive | Award | 60,296 | $N/A | $0 | |
| Dec 23, 2025 | Schabacker Marcus | Executive | Award | 7,633 | $N/A | $0 | |
| Dec 23, 2025 | Pasqualone Frank | Executive | Award | 7,633 | $N/A | $0 | |
| Dec 23, 2025 | A. Kegler George | Executive | Award | 7,633 | $N/A | $0 | |
| Dec 23, 2025 | Dewitt Sheila | Executive | Award | 7,633 | $N/A | $0 | |
| Feb 22, 2024 | Michael Coveney Kevin | Executive | Award | 60,000 | $N/A | $0 | |
| Feb 22, 2024 | J. Facchini Peter | Executive | Award | 50,000 | $N/A | $0 | |
| Feb 22, 2024 | Edward Tucker Joseph | Executive | Award | 100,000 | $N/A | $0 | |
| Sep 15, 2023 | Pasqualone Frank | Executive | Purchase | 1,000 | $2.14 | $2.1K | |
| Mar 13, 2023 | Michael Coveney Kevin | Executive | Award | 26,500 | $N/A | $0 | |
| Jan 25, 2023 | Kanubaddi Avani | Executive | Award | 10,000 | $N/A | $0 | |
| Jan 25, 2023 | Marie Hagel Jillian | Executive | Award | 12,000 | $N/A | $0 | |
| Jan 25, 2023 | Edward Tucker Joseph | Executive | Award | 44,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 1 | $2.1K | 100.0% |
Award(A) | 32 | $0 | 0.0% |
Insiders at Enveric Biosciences, Inc. are accumulating shares at an accelerated pace. With 13 insiders making 33 transactions totaling $2.1K in purchases versus $0 in sales, the net buying activity of $2.1K signals strong executive confidence. Frank Pasqualone (Executive) leads the buying activity with $2.1K in transactions across all time.